NaCl 0.9% 100ml

DRUG2 trials

Sponsors

Suzhou Municipal Hospital of Anhui Province, Zhujiang Hospital

Conditions

Atheroscleroses, IntracranialAtherosclerosis of ArteryBrain DiseasesCerebral InfarctionEndovascular TreatmentInterleukin-6IschemiaIschemic Stroke

Phase 2

Effect of Interleukin-6 Receptor Inhibition in Patients With Ischemic Stroke Undergoing Endovascular Treatment

CompletedNCT06238024

Suzhou Municipal Hospital of Anhui ProvinceEndovascular Treatment, Interleukin-6, Ischemic Stroke

Start: 2024-02-02End: 2024-09-22Updated: 2024-09-25

Phase 3

Interleukin-6 Receptor Inhibition for Symptomatic Intracranial Atherosclerosis

Not yet recruitingNCT06447701

Zhujiang HospitalAtheroscleroses, Intracranial, Atherosclerosis of Artery, Brain Diseases +4

Start: 2025-10-30End: 2029-06-30Target: 486Updated: 2025-07-28